ALFRED MOSS: Open Payments
NPI 1245294107 · GAFFNEY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,405 in 76 payments from 16 companies in 2025. Trend: 2023 $1,414 · 2024 $1,013 · 2025 $1,405
Food & beverage: $1,405
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $261 |
| Axsome Therapeutics, Inc. | 6 | $223 |
| PFIZER INC. | 11 | $187 |
| ABBVIE INC. | 17 | $169 |
| Phathom Pharmaceuticals, Inc. | 7 | $114 |
| Novo Nordisk Inc | 5 | $75 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Lundbeck LLC | 3 | $60 |
| Verity Pharmaceuticals Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $41 |
Products named: Symbravo, NURTEC ODT, FARXIGA, VOQUEZNA, VRAYLAR, BREZTRI, REXULTI, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
